Search for content, post, videos

AstraZeneca completes Japanese acquisition

Marc-Dunoyer

AstraZeneca completes purchase of Sumitomo Chemical’s stake in AstraZeneca K.K.

The company announced on March 26 that it has completed the purchase of Sumitomo Chemical’s remaining shares in AstraZeneca K.K. According to a statement the purchase was valued at approximately JPY10 billion ($102 million). This gives AstraZeneca control of the entire shareholding of AstraZeneca K.K.

“Our decision to gain full control of AstraZeneca K.K. reinforces our focus on Japan as a key growth platform,” commented Marc Dunoyer, Chief Financial Officer, AstraZeneca, in a press release.

Advertisement
Advertisement